Page last updated: 2024-08-18

monobenzone and Vitiligo

monobenzone has been researched along with Vitiligo in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19907 (21.88)18.7374
1990's5 (15.63)18.2507
2000's1 (3.13)29.6817
2010's14 (43.75)24.3611
2020's5 (15.63)2.80

Authors

AuthorsStudies
Erdoğan, A; Mutlu, HS; Solakoğlu, S1
Gu, Y; Ke, Y; Li, H; Li, Y; Li, Z; Liang, B; Lu, Y; Peng, L; Zhu, H1
Dong, J; Lai, Y; Shang, J; Yue, Y; Zhang, X; Zhong, H1
Li, QL; Liang, TS; Liu, XT; Lv, XT; Tang, N; Wang, GE; Wen, WL; Wu, YH1
Kaul, D; Kaushik, H; Kumaran, MS; Parsad, D1
Harris, JE1
Grimes, PE; Nashawati, R1
Arowojolu, OA; Elbuluk, N; Manga, P; Orlow, SJ1
Wang, S; Xu, A; Zhu, Y1
Boissy, RE; Eby, JM; Flood, K; Klarquist, J; Koshoffer, A; Le Poole, IC; Mosenson, JA; Overbeck, A; Tung, RC1
Eby, JM; Hariharan, V; Hernandez, C; Le Poole, IC; Luiten, RM; Webb, KC1
Boniface, K; Ezzedine, K; Seneschal, J; Taieb, A1
Li, Q; Lin, F; Wang, S; Xu, A; Zhu, Y1
Sarkany, R; Tan, ES1
Cabrini, DA; Carrenho, LZ; Moreira, CG; Otuki, MF; Pawloski, PL; Soley, BS1
Boissy, RE; Hariharan, V; Klarquist, J; Koshoffer, A; Le Poole, IC; McKee, MD; Reust, MJ1
AlGhamdi, KM; Kumar, A1
Luiten, RM; Melief, CJ; van den Boorn, JG1
Manga, P; Orlow, SJ; Toosi, S1
Buggiani, G; Lotti, T; Prignano, F1
Grimes, PE; Kenney, JA2
Balda, BR; Heilgemeir, GP1
Hanninen, LA; Hedges, TR; Kenyon, KR; Mosher, DB1
Oakley, AM1
Wee, TA1
Beck, MH; Lyon, CC1
Bos, JD; Bossuyt, PM; Njoo, MD; Westerhof, W1
Lerner, AB1
Forget, B; Kirkwood, J; Lerner, AB; Nordlund, JJ1
Catona, A; Lanzer, D1
Frenk, E1

Reviews

7 review(s) available for monobenzone and Vitiligo

ArticleYear
Chemical-Induced Vitiligo.
    Dermatologic clinics, 2017, Volume: 35, Issue:2

    Topics: Autoimmunity; Catechols; Hair Dyes; Humans; Hydroquinones; Hypopigmentation; Phenols; Phenylenediamines; Skin Lightening Preparations; Vitiligo

2017
Depigmentation Therapies for Vitiligo.
    Dermatologic clinics, 2017, Volume: 35, Issue:2

    Topics: Adjuvants, Immunologic; Aminoquinolines; Anisoles; Body Surface Area; Cryotherapy; Cyclopropanes; Humans; Hydroquinones; Imatinib Mesylate; Imiquimod; Low-Level Light Therapy; Patient Selection; Phenol; Protein Kinase Inhibitors; Severity of Illness Index; Skin Lightening Preparations; Vitiligo

2017
Accelerating bleaching in vitiligo: balancing benefits versus risks.
    Experimental dermatology, 2014, Volume: 23, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Humans; Hydroquinones; Imiquimod; Melanocytes; Risk Assessment; Skin Lightening Preparations; Vitiligo

2014
Depigmentation therapies for normal skin in vitiligo universalis.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:7

    Topics: Cryotherapy; Dermatologic Agents; Humans; Hydroquinones; Laser Therapy; Skin Pigmentation; Tretinoin; Vitiligo

2011
Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity.
    Pigment cell & melanoma research, 2011, Volume: 24, Issue:4

    Topics: Autoimmunity; Humans; Hydroquinones; Hypopigmentation; Melanoma; Models, Biological; Monophenol Monooxygenase; Vitiligo

2011
Should vitiligo be treated?
    Cutis, 1983, Volume: 32, Issue:4

    Topics: Black People; Humans; Hydroquinones; PUVA Therapy; Self Concept; Vitiligo

1983
The Seiji memorial lecture. Pigment stories: from vitiligo to melanomas and points in between.
    Pigment cell research, 1992, Volume: Suppl 2

    Topics: Adult; Female; Humans; Hydroquinones; Male; Melanoma; Melanosis; Methoxsalen; Nevus, Pigmented; Paraneoplastic Syndromes; Prejudice; Skin Neoplasms; Skin Pigmentation; Social Values; Trioxsalen; Ultraviolet Rays; Vitiligo

1992

Other Studies

25 other study(ies) available for monobenzone and Vitiligo

ArticleYear
Autologously transplanted dermis-derived cells alleviated monobenzone-induced vitiligo in mouse.
    Experimental dermatology, 2022, Volume: 31, Issue:9

    Topics: Animals; Dermis; Disease Models, Animal; Hair Follicle; Hydroquinones; Hypopigmentation; Melanins; Mice; Mice, Inbred C57BL; Vitiligo

2022
Mechanisms of action of
    Pharmaceutical biology, 2023, Volume: 61, Issue:1

    Topics: Animals; Drugs, Chinese Herbal; Hydroquinones; Lycium; Mice; Mice, Inbred C57BL; Vitiligo

2023
Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress.
    International journal of molecular sciences, 2023, Apr-10, Volume: 24, Issue:8

    Topics: Animals; Disease Models, Animal; Hydroquinones; Hypopigmentation; Melanocytes; Mice; Skin; Vitiligo

2023
Restraint stress promotes monobenzone-induced depigmentation in mice via the activation of glucocorticoid receptor/macrophage migration inhibitory factor signaling pathway.
    Molecular immunology, 2023, Volume: 161

    Topics: Animals; Hypopigmentation; Macrophage Migration-Inhibitory Factors; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Glucocorticoid; Signal Transduction; Vitiligo

2023
Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway.
    Journal of dermatological science, 2020, Volume: 100, Issue:2

    Topics: Biopsy; Cells, Cultured; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation; Humans; Hydroquinones; Melanins; Melanocytes; MicroRNAs; Phenols; Primary Cell Culture; Roxithromycin; Skin; Skin Pigmentation; Transforming Growth Factor beta; Vitiligo

2020
The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.
    Experimental dermatology, 2017, Volume: 26, Issue:7

    Topics: Antioxidants; Cell Line; Cell Survival; Dimethyl Fumarate; Humans; Hydroquinones; Hypopigmentation; Melanocytes; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidants; Oxidative Stress; Peroxiredoxin VI; Skin; Vitiligo

2017
A mouse model of vitiligo induced by monobenzone.
    Experimental dermatology, 2013, Volume: 22, Issue:7

    Topics: Animals; Autoimmunity; CD8-Positive T-Lymphocytes; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroquinones; Hypopigmentation; Melanocytes; Mice; Mice, Inbred C57BL; Skin; Vitiligo

2013
Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.
    Pigment cell & melanoma research, 2014, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Cell Survival; Female; HSP70 Heat-Shock Proteins; Humans; Hydroquinones; Infant, Newborn; Intracellular Space; Male; Melanocytes; Melanosomes; Middle Aged; Phenols; Protein Transport; Skin; Stress, Physiological; Subcellular Fractions; Vitiligo; Young Adult

2014
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
    Experimental dermatology, 2014, Volume: 23, Issue:8

    Topics: Aminoquinolines; Apoptosis; Chemotherapy, Adjuvant; Drug Therapy, Combination; HSP70 Heat-Shock Proteins; Humans; Hydroquinones; Imiquimod; Immunotherapy; Melanocytes; Oligodeoxyribonucleotides; Skin Lightening Preparations; Toll-Like Receptors; Treatment Outcome; Vitiligo

2014
The therapeutic effects of EGCG on vitiligo.
    Fitoterapia, 2014, Volume: 99

    Topics: Animals; Anti-Inflammatory Agents; Catechin; CD8-Positive T-Lymphocytes; Disease Models, Animal; Female; Hydroquinones; Interferon-gamma; Interleukin-6; Melanocytes; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Skin Pigmentation; Transcriptome; Tumor Necrosis Factor-alpha; Vitiligo

2014
Topical monobenzyl ether of hydroquinone is an effective and safe treatment for depigmentation of extensive vitiligo in the medium term: a retrospective cohort study of 53 cases.
    The British journal of dermatology, 2015, Volume: 172, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Child; Dermatologic Agents; Female; Humans; Hydroquinones; Male; Maximum Allowable Concentration; Middle Aged; Retrospective Studies; Treatment Outcome; Vitiligo; Young Adult

2015
Pre-clinical evidences of Pyrostegia venusta in the treatment of vitiligo.
    Journal of ethnopharmacology, 2015, Jun-20, Volume: 168

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bignoniaceae; Croton Oil; Cytokines; Edema; Female; Hydroquinones; Male; Melanins; Mice; Mice, Inbred C57BL; Phytotherapy; Plant Extracts; Plant Leaves; Reactive Oxygen Species; Skin; Vitiligo

2015
Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
    The Journal of investigative dermatology, 2010, Volume: 130, Issue:1

    Topics: Annexin A5; Apoptosis; Biomarkers; Caspase 3; Cell Survival; Cells, Cultured; DNA Fragmentation; Fibroblasts; Humans; Hydroquinones; Keratinocytes; Melanocytes; Necrosis; Organ Culture Techniques; Phenols; Poly(ADP-ribose) Polymerases; Skin; Skin Pigmentation; Vitiligo

2010
Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.
    The Journal of investigative dermatology, 2012, Volume: 132, Issue:11

    Topics: Autoimmunity; Cell Line; DNA-Binding Proteins; Gene Expression; Humans; Hydroquinones; Infant, Newborn; Interleukin-6; Interleukin-8; Melanocytes; Oxidative Stress; Phenols; Regulatory Factor X Transcription Factors; Skin; Transcription Factors; Unfolded Protein Response; Up-Regulation; Vitiligo; X-Box Binding Protein 1

2012
New and experimental treatments of vitiligo and other hypomelanoses.
    Dermatologic clinics, 2007, Volume: 25, Issue:3

    Topics: Dermatologic Agents; Humans; Hydroquinones; Hypopigmentation; Keratinocytes; Laser Therapy; Melanocytes; Phototherapy; Skin Pigmentation; Skin Transplantation; Ultraviolet Therapy; Vitiligo

2007
How we treat vitiligo.
    Cutis, 1983, Volume: 32, Issue:4

    Topics: Administration, Oral; Administration, Topical; Child; Furocoumarins; Humans; Hydroquinones; Methods; Methoxsalen; Photosensitivity Disorders; PUVA Therapy; Trioxsalen; Vitiligo

1983
[Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    MMW, Munchener medizinische Wochenschrift, 1981, Jan-09, Volume: 123, Issue:2

    Topics: Adult; Female; Humans; Hydroquinones; Melanins; Melanosis; Skin; Skin Pigmentation; Vitiligo

1981
Corneal and conjunctival effects of monobenzone in patients with vitiligo.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1983, Volume: 101, Issue:1

    Topics: Adult; Aged; Conjunctiva; Conjunctival Diseases; Cornea; Corneal Diseases; Female; Humans; Hydroquinones; Male; Middle Aged; Vitiligo

1983
Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    The Australasian journal of dermatology, 1996, Volume: 37, Issue:2

    Topics: Adult; Facial Dermatoses; Humans; Hydroquinones; Male; PUVA Therapy; Recurrence; Skin Pigmentation; Vitiligo

1996
A case report of extensive vitiligo.
    Hawaii medical journal, 1997, Volume: 56, Issue:2

    Topics: Adult; Diagnosis, Differential; Female; Humans; Hydroquinones; Melanocytes; Ultraviolet Rays; Vitiligo

1997
Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo.
    Contact dermatitis, 1998, Volume: 39, Issue:3

    Topics: Dermatitis, Allergic Contact; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Hydroquinones; Middle Aged; Patch Tests; Vitiligo

1998
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology.
    Archives of dermatology, 1999, Volume: 135, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Child; Evidence-Based Medicine; Female; Humans; Hydroquinones; Laser Therapy; Male; Netherlands; Skin Transplantation; Treatment Outcome; Ultraviolet Therapy; Vitiligo

1999
Dermatitis produced by applications of monobenzone in patients with active vitiligo.
    Archives of dermatology, 1985, Volume: 121, Issue:9

    Topics: Adult; Dermatologic Agents; Drug Eruptions; Female; Humans; Hydroquinones; Middle Aged; Patch Tests; Skin Pigmentation; Vitiligo

1985
Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
    The Medical journal of Australia, 1987, Mar-16, Volume: 146, Issue:6

    Topics: Aged; Female; Humans; Hydroquinones; Middle Aged; Pigmentation Disorders; Vitiligo

1987
[Treatment of vitiligo].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1986, Volume: 37, Issue:1

    Topics: Adrenal Cortex Hormones; Clobetasol; Combined Modality Therapy; Humans; Hydroquinones; PUVA Therapy; Skin; Skin Pigmentation; Vitiligo

1986